Back to Agenda
Session 8 Track 2: Business Benefits and Insights Gained from Regulatory Intelligent Automation Implementations
Session Chair(s)
Cary Smithson, MBA
Managing Partner
Leapahead Solutions, Inc., United States
Session 8 Track 2: Business Benefits and Insights Gained from Regulatory Intelligent Automation Implementations
Learning Objective : - Identify how sponsor companies are reaping value from their intelligent automation initiatives in Regulatory
- Differentiate between use cases that provide greater value from those that are not worth pursuing
- Discuss approaches for implementing and scaling IA technologies and how to deal with challenges along the way
- Propose ways sponsor companies can influence vendors collectively
Speaker(s)
![Catalina Rojas Fallas, PharmD, MSc](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panelist
Catalina Rojas Fallas, PharmD, MSc
F. Hoffmann-La Roche Ltd, Switzerland
International Regulatory Team Lead
![Francis Quinn](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panelist
Francis Quinn
Pfizer, Inc., United States
Regional Director, AMER Publishing
Panelist
Chris Whalley
Pfizer Inc, United States
Senior Director and Head of Global Regulatory Intelligence
Have an account?